ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Clinical trial NCT04620239 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04620239
Sponsor: Steba Biotech S.A.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Transitional Cell Cancer of Renal Pelvis and Ureter

Start date: 2021-03-22
Primary completion: 2026-07-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.